CBO: Generics Bill Would Save US $4.8 Billion
The US Congressional Budget Office has estimated that a current bill to prevent brand-name pharmaceutical companies from paying generic producers to delay the release of generic drugs into the market could save the US budget some $4.8 billion over 10…
